Vanessa Gonzalez
Family · Salt Lake City, UTNPI 1710394291
Payments from drug & device makers
Across 210 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- LEO Pharma Inc.$1K
- UCB, Inc.$590
- E.r. Squibb & Sons, L.L.C.$362
- Sun Pharmaceutical Industries Inc.$354
- Novartis$290
- plus $2K from 15 others
What the payments were for
- Consulting fees$1,12820%
- Food & beverage$4,15475%
- Education$2865%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,289 |
| LEO Pharma Inc. | 3 | $1,146 |
| UCB, Inc. | 28 | $590 |
| E.r. Squibb & Sons, L.L.C. | 10 | $362 |
| Sun Pharmaceutical Industries Inc. | 16 | $354 |
| Novartis | 12 | $290 |
| Regeneron Healthcare Solutions, Inc. | 8 | $233 |
| Pfizer | 14 | $224 |
| Sanofi | 11 | $206 |
| Johnson & Johnson | 6 | $197 |
| Galderma Laboratories, L.p. | 8 | $167 |
| Lilly USA, LLC | 7 | $131 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $76 |
| Amgen | 4 | $75 |
| Dermavant Sciences, Inc. | 3 | $58 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $38 |
| Incyte Corporation | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Dermira, Inc. | 1 | $15 |
| EPI Health, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,567 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $61,809 |
| Betamethasone Dipropionate | 13 | $831 |
| Econazole Nitrate | 15 | $368 |
| Triamcinolone Acetonide | 16 | $106 |
Paid to pharmacies, not to this prescriber.
Other family in Salt Lake City
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Mary SteinbackSalt Lake City$189K
- Jennalyn MayeuxSalt Lake City$151K
- Kacie Doyle-DelgadoSalt Lake City$80K
- Melonie ThompsonSalt Lake City$45K
- Michelle LitchmanSalt Lake City$44K
- Keisa LynchSalt Lake City$39K
- Christina CardonSalt Lake City$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.